Clinical Trials Logo

Procedural Sedation clinical trials

View clinical trials related to Procedural Sedation.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06368219 Not yet recruiting - Procedural Sedation Clinical Trials

Propofol or Benzodiazepine Combined With Ketamine for Procedural Sedation in Emergency Setting

Start date: April 2024
Phase: Early Phase 1
Study type: Interventional

This single blinded parallel randomized clinical trial will be conducted on 50 patients presented to Emergency Department of Alexandria Main University Hospital who are indicated for procedural sedation. All patients included in the study will be allocated randomly using computer software with concealment of randomization in to two groups: - Group A: 25 patients will receive ketamine (0.5 mg/kg) plus midazolam (0.05 mg/kg) - Group B: 25 patients will receive ketamine (0.5 mg/kg) plus propofol (0.5 mg/kg) Additional ketamine (0.25 mg/kg) will be administered in case of inadequate sedation in both groups. the two groups will be compared as regard incidence of complications World Society of Intravenous Anesthesia (SIVA) international sedation task force to standardize reporting adverse events

NCT ID: NCT05757622 Not yet recruiting - Procedural Sedation Clinical Trials

Electroencephalogram Based Real-Time Sedation Level Prediction

EBSPA
Start date: March 1, 2023
Phase:
Study type: Observational

This is an observational pilot study. Patients undergoing elective surgery or Cath lab interventions under general anesthesia or procedural sedation at the department of anesthesiology at the UMCG will be enrolled. 1. Recruitment procedure: Patients identified as eligible for the study by research/clinical staff will be enrolled after written informed consent. Clinical staff involved in this study will approach the patient for obtaining informed consent prior to the scheduled procedure, according to the UMCG´s daily published OR/Cath lab schedule. Patients enrolled in this study will receive standard clinical care, as defined in the standard operating procedures of the department of Anesthesiology. 2. Monitor and recording set up: 1. A vital sign monitor will continuously record routine physiological data, including ECG, noninvasive and/or invasive blood pressure (blood pressure cuff and/or arterial line), and pulse oximetry. 2. The noninvasive EEG-monitor A disposable sensor will be attached to the forehead of the patient and passive recording of EEG and physiological data will begin prior to induction of anesthesia at the OR or Cath lab. 3. Vital sign monitor and EEG-monitor used for this study are mounted permanently on the anesthesia machine and sedation workstation which is used routinely at the department of Anesthesiology and data obtained are directly streamed to the UMCG patient data record system , and stored monitor for case-based wave analysis. 3. Sedation/Pain assessments: As per routine clinical practice, the investigators will use Modified Observer's Assessment of Alertness/Sedation Scale (MOAA/S) scoring system for sedation assessment system for pain assessment. During each assessment MOAA/S scores will be determined prior to induction of anesthesia or sedation, during the procedure, and after the procedure until the patient leaves the operating room/cath lab.

NCT ID: NCT03635398 Not yet recruiting - Procedural Sedation Clinical Trials

Intranasal Midazolam for Pediatric Pre-procedural Sedation and Pre-procedural Anti-anxiety Using sipNose Device - a Randomized Controlled Study

Start date: August 2018
Phase: N/A
Study type: Interventional

A Three-arm, Randomized Controlled Trial for Pediatric Pre-procedural Sedation and Pre-procedural Anti-anxiety: Intranasal Midazolam by SipNose versus MAD Versus oral administration

NCT ID: NCT01227174 Not yet recruiting - Propofol Clinical Trials

Safety and Efficacy of Propofol Only Sedation in Oral and Maxillofacial Surgery

Start date: January 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if the use of propofol only to achieve procedural sedation for the removal of third molars is both safe and effective.